Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMC 2956868)

Published in Contemp Clin Trials on July 30, 2010

Authors

Beverly B Green1, C Y Wang, Kathryn Horner, Sheryl Catz, Richard T Meenan, Sally W Vernon, David Carrell, Jessica Chubak, Cynthia Ko, Sharon Laing, Andy Bogart

Author Affiliations

1: Group Health Permanente, Seattle, WA 98101, United States. green.b@ghc.org

Associated clinical trials:

Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up (SOS) | NCT00697047

Articles citing this

An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med (2013) 2.89

Nonparticipation in a population-based trial to increase colorectal cancer screening. Am J Prev Med (2012) 1.04

Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med (2013) 0.97

Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev (2013) 0.92

Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med (2014) 0.91

Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med (2014) 0.88

Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev (2014) 0.85

An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med (2015) 0.82

Underuse of surveillance colonoscopy in patients at increased risk of colorectal cancer. Am J Gastroenterol (2014) 0.82

Effectiveness of a theory-based intervention to increase colorectal cancer screening among Iranian health club members: a randomized trial. J Behav Med (2013) 0.78

Adaptation of an Evidence-Based Colorectal Cancer Screening Program Using the Consolidated Framework for Implementation Research. Prev Chronic Dis (2015) 0.78

Using an Automated Data-driven, EHR-Embedded Program for Mailing FIT kits: Lessons from the STOP CRC Pilot Study. J Gen Pract (Los Angel) (2014) 0.78

Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer (2015) 0.78

Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH). J Am Board Fam Med (2016) 0.77

A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer (2017) 0.75

Reasons for never and intermittent completion of colorectal cancer screening after receiving multiple rounds of mailed fecal tests. BMC Public Health (2017) 0.75

Articles cited by this

Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57

Organizing care for patients with chronic illness. Milbank Q (1996) 18.64

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86

Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87

Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med (2000) 6.90

Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev (2007) 5.63

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst (2007) 3.80

Handling uncertainty in cost-effectiveness models. Pharmacoeconomics (2000) 3.37

Motivational interviewing in health settings: a review. Patient Educ Couns (2004) 3.30

Use of colorectal cancer tests--United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep (2008) 3.12

Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med (2009) 2.65

Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer (2006) 2.47

Publication guidelines for improvement studies in health care: evolution of the SQUIRE Project. Ann Intern Med (2008) 2.37

Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am J Psychiatry (2007) 2.20

Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev (1997) 2.13

Modeling adherence to colorectal cancer screening. Prev Med (1994) 1.87

Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med (2003) 1.73

Automated telephone calls improved completion of fecal occult blood testing. Med Care (2010) 1.50

Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev (2005) 1.38

Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care (2008) 1.37

Chronic care costs in managed care. Health Aff (Millwood) (1997) 1.23

Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening. Cancer Epidemiol Biomarkers Prev (2008) 1.23

Enhancing the use and quality of colorectal cancer screening. Evid Rep Technol Assess (Full Rep) (2010) 1.14

Decision counseling in cancer prevention and control. Health Psychol (2005) 0.98

Numerical equivalence of imputing scores and weighted estimators in regression analysis with missing covariates. Biostatistics (2006) 0.96

Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening in Ontario, Canada--a replication study. Cancer Epidemiol Biomarkers Prev (2008) 0.95

Improving rescreening in community clinics: does a system approach work? J Community Health (2006) 0.88

Articles by these authors

A high-throughput Arabidopsis reverse genetics system. Plant Cell (2002) 7.58

Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev (2006) 6.67

Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer (2004) 6.41

Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10

Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA (2008) 6.04

NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science (2000) 5.20

Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care (2003) 4.60

Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58

Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med (2012) 4.07

Intimate partner violence: prevalence, types, and chronicity in adult women. Am J Prev Med (2006) 3.93

Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet (2011) 3.85

Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2008) 3.64

Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care (2005) 3.53

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science (1997) 3.32

Intimate partner violence and women's physical, mental, and social functioning. Am J Prev Med (2006) 3.25

Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol (2000) 3.23

Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis (2003) 3.19

Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med (1978) 3.18

A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg (2013) 3.06

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat (2012) 3.02

National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst (2003) 2.99

An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med (2013) 2.89

Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J Exp Med (1980) 2.89

Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med (2009) 2.84

Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A (1977) 2.80

Studies with B-cell allo- and hetero-antisera: parallel reactivity and special properties. Scand J Immunol (1976) 2.74

Surveying physicians: do components of the "Total Design Approach" to optimizing survey response rates apply to physicians? Med Care (2002) 2.68

A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer (2007) 2.64

Patient web services integrated with a shared medical record: patient use and satisfaction. J Am Med Inform Assoc (2007) 2.60

cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol Cell Biol (1992) 2.55

Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Proc Natl Acad Sci U S A (1986) 2.54

Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol (2001) 2.52

Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer. J Natl Cancer Inst (2012) 2.52

Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care (2008) 2.48

Prevalence and incidence of interstitial cystitis in a managed care population. J Urol (2005) 2.46

Sequence of the genome RNA of rubella virus: evidence for genetic rearrangement during togavirus evolution. Virology (1990) 2.36

Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer (2007) 2.30

Opportunities and challenges for measuring cost, quality, and clinical effectiveness in health care. Med Care Res Rev (2004) 2.27

Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomarkers Prev (2004) 2.26

The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. Blood (1985) 2.24

Genomic duplication, fractionation and the origin of regulatory novelty. Genetics (2004) 2.22

Idiotype-like molecules on cells of a human T cell leukemia. J Exp Med (1983) 2.19

A national survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev Med (2003) 2.19

Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) (2006) 2.17

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. J Natl Cancer Inst (2005) 2.16

Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron (2013) 2.13

Effect of rocuronium compared with succinylcholine on intraocular pressure during rapid sequence induction of anaesthesia. Br J Anaesth (1999) 2.12

Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence. Am J Epidemiol (2014) 2.09

Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol (2013) 2.09

Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J Exp Med (1988) 2.07

Clonidine in patients undergoing noncardiac surgery. N Engl J Med (2014) 2.07

Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med (1988) 2.05

Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med (2003) 2.05

Analyzing the heterogeneity and complexity of Electronic Health Record oriented phenotyping algorithms. AMIA Annu Symp Proc (2011) 2.03

Blood-tissue exchange via transport and transformation by capillary endothelial cells. Circ Res (1989) 2.02

Respiratory depression after extradural fentanyl. Br J Anaesth (1992) 1.97

The nature of the stimulatory cell in human allogeneic and autologous MLC reactions; role of isolated IgM-bearing B cells. J Immunol (1979) 1.96

Effectiveness of Cultivando la Salud: a breast and cervical cancer screening promotion program for low-income Hispanic women. Am J Public Health (2009) 1.95

Computationally efficient algorithms for convection-permeation-diffusion models for blood-tissue exchange. Ann Biomed Eng (1992) 1.95

The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol Cell Biol (1993) 1.94

Toward patient-centered cancer care: patient perceptions of problematic events, impact, and response. J Clin Oncol (2012) 1.91

Promoting regular mammography screening I. A systematic assessment of validity in a randomized trial. J Natl Cancer Inst (2008) 1.89

Conserved noncoding sequences in the grasses. Genome Res (2003) 1.88

Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer (2002) 1.87

Prevalence of interstitial cystitis symptoms in a managed care population. J Urol (2005) 1.86

Which women aren't getting mammograms and why? (United States). Cancer Causes Control (2007) 1.85

Cancer and colorectal cancer: knowledge, beliefs, and screening preferences of a diverse patient population. Fam Med (2005) 1.81

Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci U S A (1991) 1.81

Importance of multi-modal approaches to effectively identify cataract cases from electronic health records. J Am Med Inform Assoc (2012) 1.79

An Asian-Native American paternal lineage identified by RPS4Y resequencing and by microsatellite haplotyping. Ann Hum Genet (1999) 1.78

Medical and psychosocial diagnoses in women with a history of intimate partner violence. Arch Intern Med (2009) 1.77

Expression of Ia-like antigens on cultured human malignant melanoma cell lines. Proc Natl Acad Sci U S A (1978) 1.76

Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol (1978) 1.76

Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev (2008) 1.72

Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model. AIDS Patient Care STDS (2006) 1.72

National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst Monogr (2004) 1.70

The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med (2010) 1.68

Colorectal cancer screening among Latinos from U.S. cities along the Texas-Mexico border. Cancer Causes Control (2007) 1.64

MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene (2012) 1.63

Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease. Public Health Nutr (2002) 1.62

Inherited polymorphism of the human T-cell antigen receptor detected by a monoclonal antibody. Proc Natl Acad Sci U S A (1986) 1.61

Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine (1999) 1.61

Platelet-derived growth factor receptor alpha-subunit gene (Pdgfra) is deleted in the mouse patch (Ph) mutation. Proc Natl Acad Sci U S A (1991) 1.61

Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health (2003) 1.57

Healthcare utilization and costs for women with a history of intimate partner violence. Am J Prev Med (2007) 1.57

Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. Am J Public Health (2004) 1.55

Behind closed doors: physician-patient discussions about colorectal cancer screening. J Gen Intern Med (2009) 1.55

A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev (2003) 1.54

How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet (2003) 1.54

Correlates of repeat and recent mammography for women ages 45 to 75 in the 2002 to 2003 Health Information National Trends Survey (HINTS 2003). Cancer Epidemiol Biomarkers Prev (2006) 1.54

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J (1999) 1.52

Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity. J Exp Med (1982) 1.50

Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis. Qual Life Res (2005) 1.49

Prevalence and severity of undiagnosed urinary incontinence in women. Am J Med (2009) 1.48

Patient use of secure electronic messaging within a shared medical record: a cross-sectional study. J Gen Intern Med (2009) 1.47

Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47